logo

For the Inventor, By the Inventor

Slough, United Kingdom

Celltech R&d Limited


USPTO Granted Patents = 68

% Expired Patents = 61.8



Forward Citations = 1,178

Loading Chart...
Loading Chart...

99 inventors (with patents filed for the assignee):

goldMedal John Robert Porter (18 out of 67 patents)

silverMedal John Clifford Head (18 out of 38 patents)

bronzeMedal Sarah Catherine Archibald (13 out of 26 patents)

4.  Graham John Warrellow (13 out of 59 patents)

5.  Barry John Langham (10 out of 26 patents)

6.  Diljeet Singh Athwal (8 out of 21 patents)

7.  John A Latham (7 out of 125 patents)

8.  Rikki Peter Alexander (7 out of 41 patents)

9.  John Robert Adair (7 out of 18 patents)

10.  John Spencer Emtage (7 out of 17 patents)

11.  Janeen Marsha Linsley (7 out of 7 patents)

12.  Jeremy Martin Davis (6 out of 19 patents)

13.  David Guenther Winkler (5 out of 33 patents)

14.  Timothy John Norman (5 out of 26 patents)

15.  Sean Proll (5 out of 5 patents)


Core Competencies:
Antibodies
Bone Density
Cytokines
Psoriasis
Humanized Antibodies
Polypeptides
Ligands
Recombinant Antibodies
Phenylalanine Derivatives
Chimeric Antibodies
Genomic Deletions
Transmembrane Components

68 patents:

1. 8304200 - Methods for obtaining antibodies (2012-11-06),
2. 8227441 - Methods to increase or decrease bone density (2012-07-24),
3. 8110357 - Method for detecting an individual who is afflicted with or a carrier for Van Buchem's disease (2012-02-07),
4. 7989594 - Modified antibody fab fragments (2011-08-02),
5. 7985834 - Compositions and methods for increasing bone mineralization (2011-07-26),
6. 7879982 - 19.5 polypeptide antibodies useful for diagnosing or treating psoriasis (2011-02-01),
7. 7872103 - Modulating immune responses (2011-01-18),
8. 7850968 - Manipulation of cytokine levels using CD83 gene products (2010-12-14),
9. 7799523 - [object Object] (2010-09-21),
10. 7771969 - Methods for obtaining antibodies (2010-08-10),
11. 7655420 - Methods to increase or decrease bone density (2010-02-02),
12. 7618629 - Manipulation of cytokine levels using CD83 gene products (2009-11-17),
13. 7578999 - Antibodies specific for sclerostin (2009-08-25),
14. 7566771 - Humanised antibodies (2009-07-28),
15. 7531676 - Lipids (2009-05-12),
Company Overview
Celltech R&D Limited, based in Slough, GB, specializes in the development of innovative antibody therapies. The company focuses on advancing treatments related to bone density, psoriasis, and various cytokine-related conditions. With expertise in humanized antibodies, polypeptides, and recombinant antibodies, Celltech is dedicated to enhancing therapeutic options through cutting-edge research in antibody technology. Its commitment to scientific excellence positions it as a key player in the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Celltech R&d Limited USPTO Patent Assignee Logo
68 Patents

#5 in Slough

#271 in United Kingdom

#10,888 in the World

Slough, GB
Slough, United Kingdom

Celltech R&d Limited

Forward Citations = 1,178

99 inventors:

goldMedal John Robert Porter (18 out of 67 patents)

silverMedal John Clifford Head (18 out of 38 patents)

bronzeMedal Sarah Catherine Archibald (13 out of 26 patents)

4.  Graham John Warrellow (13 out of 59 patents)

5.  Barry John Langham (10 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Celltech R&d Limited. Retrieved from https://idiyas.com/company/celltech-r-and-d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…